IFIH1 and interstitial lung disease: However, patients with anti-MDA5 antibodies had a slightly elevated risk of ILD (adjusted OR = 3.70, 95% CI: 1.27–10.78; p = 0.017) compared to those without anti-MDA5 antibodies (see Supplementary Table 2 for details).